Mineral Resources shares have recovered slightly after the company downgraded its volume guidance for the Onslow Iron project on Tuesday, even as wealth management firm Morgans raised its price target ...

Clarity Pharmaceuticals rose at the open after it reported it had imaged its first patient for its phase three diagnostic trial in participants with biochemical recurrence of prostate cancer.

Macquarie has upgraded its rating on Web Travel Group after the B2B travel company's positive full-year result sent shares ...

Elon Musk has announced that he is leaving his role in the Trump administration, a day after criticising the US President's ...

Macquarie Asset Management fund is acquiring a portfolio that holds the concessionaires for four toll roads in northeast Brazil and one in central Brazil from private equity firm Monte Capital ...

The Australian Competition and Consumer Commission has outlined concerns over Elders' proposed acquisition of rival Delta ...

A US federal court has blocked US President Donald Trump's "Liberation Day" tariffs, announced last month, ruling that he did ...

Resolute Mining has denied receiving formal communications from the Guinean government that its exploration permits could be ...

Metrics Credit Partners' private debt fund Metrics Master Income Trust has entered a trading halt on the ASX as it launches a ...

The Trump administration has directed US electronic design automation (EDA) companies, such as Cadence, Synopsys and Siemens ...

Iron ore miner Champion Iron has reported a 39% drop in net profit for the year ending 31 March, as shutdowns at the ...

Medical product wholesaler and distributor EBOS has confirmed that its major shareholder Sybos will sell NZ$949 million ($881 ...